The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...

Johnson & Johnson is increasing its dividend for the 63rd consecutive year. This further cements the healthcare giant's ...

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...

For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...

Johnson & Johnson on Tuesday reported better-than-expected first-quarter results and lifted its sales forecast for the full ...

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt primarily within the company's medical technology unit, which makes a range of ...